https://www.newsmax.com/health/health-news/multiple-sclerosis/2025/04/06/id/1205835/
"They persuaded pharmaceutical company Genentech to back testing. In 2006, they got resounding results: treatments targeting B cells were associated with "a dramatic, more than 90-percent reduction in brain inflammation," Hauser said.
But everyone who develops MS has had EBV first..."
